The role of tissue factor in metastasising, neoangiogenesis and hemostasis in cancer-Reference-Cited by-同舟云学术

The role of tissue factor in metastasising, neoangiogenesis and hemostasis in cancer

Published:2019-07-26 Issue:2 Volume:14 Page:70-85
ISSN:2413-4023
Container-title:Oncohematology
language:
Short-container-title:Onkogematologiâ

Author:

Kovalenko T. A.¹,Panteleev M. A.²^ORCID,Sveshnikova A. N.³^ORCID

Affiliation:

1. Lomonosov Moscow State University; Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences

2. Lomonosov Moscow State University; Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences; Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia;

3. Lomonosov Moscow State University; Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences; Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia;

Abstract

Tissue factor, being the main initiator of the blood coagulation in vivo, is involved in a number of physiological processes, such as angiogenesis or cell migration. These processes are not only significant for normal physiology, but also play a role in the development and progression of oncological diseases. This review presents data on the structure of tissue factor, its expression in normal conditions and in cancer, its role in thrombosis development associated with cancer, in angiogenesis and in metastasis. The involvement of tissue factor in such a wide range of physiological processes important for the progression of cancer makes it an attractive target molecule for therapy.

Publisher

Publishing House ABV Press

Subject

Oncology,Hematology

Reference203 articles.

1. Silva D.D., Noronha J.A.P., Silva V.D., Carvalhal G.F. Increased tissue factor expression is an independent predictor of mortality in clear cell carcinoma of the kidney. Int Braz J Urol 2014;40(4):499–506. DOI: 10.1590/S1677-5538.IBJU.2014.04.08.

2. Maciel E.O., Carvalhal G.F., da Silva V.D. et al. Increased tissue factor expression and poor nephroblastoma prognosis. J Urol 2009;182(4):1594–9. DOI: 10.1016/j.juro.2009.06.011.

3. Silva D.D., Noronha J.A.P., Silva V.D., Carvalhal G.F. Increased tissue factor expression is an independent predictor of mortality in clear cell carcinoma of the kidney. Int Braz J Urol 2014;40(4):499–506. DOI: 10.1590/S1677-5538.IBJU.2014.04.08.

4. Davis M.E. Glioblastoma: overview of disease and treatment. Clin J Oncol Nurs 2016;20(5 Suppl):S2–8. DOI: 10.1188/16.CJON.S1.2-8.

5. Davis M.E. Glioblastoma: overview of disease and treatment. Clin J Oncol Nurs 2016;20(5 Suppl):S2–8. DOI: 10.1188/16.CJON.S1.2-8.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Platelet Activation in the Development and Metastasis of Solid Tumors;Российский физиологический журнал им И М Сеченова;2024-06-28

2. Dissecting thrombus-directed chemotaxis and random movement in neutrophil near-thrombus motion in flow chambers;BMC Biology;2024-05-20

3. Role of Platelet Activation in the Development and Metastasis of Solid Tumors;Journal of Evolutionary Biochemistry and Physiology;2024-01